Your session is about to expire
← Back to Search
Dupilumab for Conjunctivitis
Study Summary
This trial will test whether Dupilumab is effective in treating the signs and symptoms of atopic keratoconjunctivitis (AKC), a type of eye inflammation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 188 Patients • NCT04033367Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there other existing studies that have used Dupilumab?
"Dupilumab is being studied in 52 different medical trials, 14 of which are Phase 3 clinical studies. Many of the research sites for Dupilumab are located in Louisville, Kentucky; however, there are 2662 total locations running these kinds of tests."
Does the FDA recognize Dupilumab as a safe medication?
"While Phase 2 trials don't have definitive evidence supporting a medication's efficacy, there is some data backing Dupilumab's safety. Therefore, it received a score of 2."
What are some of the most common reasons doctors prescribe Dupilumab?
"Dupilumab is a medication that dermatologists often prescribe to patients with atopic dermatitis. It can also be used as a corticosteroid-sparing agent for eosinophilic asthma and other conditions."
Is this study still looking for volunteers?
"Yes, that is correct. The trial information on clinicaltrials.gov indicates that the study is actively enrolling patients."
Has this research been done before?
"There have been a total of 52 clinical trials completed or currently underway for Dupilumab as of right now. These studies are taking place in 455 cities across 43 countries. The first trial was conducted in 2015 by Sanofi and involved 880 individuals. This study reached the third stage of drug approval (Phase 3) and, since then, 54 more trials have concluded."
How many research subjects are you following in this experiment?
"The information available on clinicaltrials.gov verifies that this study is still recruiting patients. The trial was posted on February 10th, 2020 and updated November 23rd, 2021. There are 42 spots open across 14 different enrolment centres."
In how many different settings is this research being conducted?
"There are multiple locations looking for patients to enroll in this trial, including 14 different sites. For example, Eye Associates of Central Texas in Round Rock, Vita Eye Clinic in Shelby, and University of Michigan- Kellogg Eye Center in Ann Arbor are all currently recruiting."
Share this study with friends
Copy Link
Messenger